Fortrea Holdings/$FTRE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Fortrea Holdings
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Ticker
$FTRE
Sector
Primary listing
Employees
14,500
Headquarters
Website
Fortrea Holdings Metrics
BasicAdvanced
$876M
-
-$11.38
1.80
-
Price and volume
Market cap
$876M
Beta
1.8
52-week high
$23.65
52-week low
$3.97
Average daily volume
2M
Financial strength
Current ratio
1.019
Quick ratio
0.871
Long term debt to equity
195.961
Total debt to equity
210.862
Interest coverage (TTM)
-0.81%
Profitability
EBITDA (TTM)
8.2
Gross margin (TTM)
19.73%
Net profit margin (TTM)
-37.57%
Operating margin (TTM)
-2.67%
Effective tax rate (TTM)
-0.08%
Revenue per employee (TTM)
$190,000
Management effectiveness
Return on assets (TTM)
-1.42%
Return on equity (TTM)
-100.49%
Valuation
Price to revenue (TTM)
0.318
Price to book
1.49
Price to tangible book (TTM)
-0.85
Price to free cash flow (TTM)
-8.443
Free cash flow yield (TTM)
-11.84%
Free cash flow per share (TTM)
-1.143
Growth
Revenue change (TTM)
-0.53%
Earnings per share change (TTM)
229.26%
What the Analysts think about Fortrea Holdings
Analyst ratings (Buy, Hold, Sell) for Fortrea Holdings stock.
Bulls say / Bears say
Second-quarter 2025 revenue increased 7.2% year-over-year to $710.3 million, well ahead of analyst expectations at $629.4 million, showing strong sales momentum (Reuters).
Management raised full-year 2025 revenue forecast to $2.6 billion–$2.7 billion and reaffirmed adjusted EBITDA guidance of $170 million–$200 million, indicating ongoing confidence in growth prospects (Reuters).
Backlog rose 2.5% year-over-year to $7,547 million—equal to approximately 2.8 quarters of revenue—giving solid future revenue visibility (Investing.com).
GAAP net loss widened to $(374.9) million in Q2 2025 due to a $309.1 million non-cash goodwill impairment charge, highlighting persistent valuation write-down risk for the company (GlobeNewswire).
Adjusted EBITDA margin fell to 7.7% in Q2 2025 from 8.3% a year earlier, reflecting weaker operating leverage and putting pressure on profit margins (Investing.com).
Net debt totaled $1,110.8 million as of June 30, 2025, resulting in a 5.4× net leverage ratio, which raises questions about the company’s balance sheet strength and its financial flexibility (Investing.com).
Data summarised monthly by Lightyear AI. Last updated on 29 Aug 2025.
Fortrea Holdings Financial Performance
Revenues and expenses
Fortrea Holdings Earnings Performance
Company profitability
Fortrea Holdings News
AllArticlesVideos
FTRE Deadline: Rosen Law Firm Urges Fortrea Holdings, Inc. (NASDAQ: FTRE) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Business Wire·1 month ago
FTRE INVESTOR ALERT: Kirby McInerney LLP Notifies Fortrea Holdings Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
Business Wire·2 months ago
Fortrea Holdings Inc. (FTRE) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of August 1, 2025 Deadline
Accesswire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Fortrea Holdings stock?
Fortrea Holdings (FTRE) has a market cap of $876M as of August 29, 2025.
What is the P/E ratio for Fortrea Holdings stock?
The price to earnings (P/E) ratio for Fortrea Holdings (FTRE) stock is 0 as of August 29, 2025.
Does Fortrea Holdings stock pay dividends?
No, Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders as of August 29, 2025.
When is the next Fortrea Holdings dividend payment date?
Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders.
What is the beta indicator for Fortrea Holdings?
Fortrea Holdings (FTRE) has a beta rating of 1.8. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.